The Swiss Biotech Association is launching the Swiss biotech Insight event series, designed to cover a portfolio of topics mirroring the biopharma product life cycle, namely from ideation and research to commercialization and patient benefit. The three main areas covered are discovery, development and commercialization.
At the first event of the Insight series, we join forces with Parexel to address major clinical trial strategy challenges, including the growing complexity of trials, changing regulations, spiraling costs, and patient access. The meeting will explore the impact of real world data science, adaptive clinical trial design, biomarkers and more.
More information can be obtained here.